Protagenic Therapeutics . Common Stock Stock Forecast

Sell candidate since Jun 12, 2026 Gain 1.25%

The Protagenic Therapeutics, Inc. Common stock price gained 1.25% on the last trading day (Tuesday, 16th Jun 2026), rising from $0.400 to $0.405. During the last trading day the stock fluctuated 0% from a day low at $0.405 to a day high of $0.405. The price has been going up and down for this period, and there has been a -19% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 thousand more shares were traded than the day before. In total, 3 thousand shares were bought and sold for approximately $1.34 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.364 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -15.41% during the next 3 months and, with a 90% probability hold a price between $0.308 and $0.80 at the end of this 3-month period.

PTIX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Protagenic Therapeutics, Inc. Common has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Protagenic Therapeutics, Inc. Common stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.492 and $0.583. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 28, 2026, and so far it has fallen -61.06%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Protagenic Therapeutics, Inc. Common stock

Protagenic Therapeutics, Inc. Common finds support from accumulated volume at $0.401 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0 between high and low, or 0%. For the last week, the stock has had daily average volatility of 7.00%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PTIX) For The Upcoming Trading Day Of Wednesday 17th

For the upcoming trading day on Wednesday, 17th we expect Protagenic Therapeutics, Inc. Common Stock to open at $0.405, and during the day (based on 14 day Average True Range), to move between $0.368 and $0.442, which gives a possible trading interval of +/-$0.0738 (+/-20.06%) up or down from last closing price. If Protagenic Therapeutics, Inc. Common Stock takes out the full calculated possible swing range there will be an estimated 20.06% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.401 (1.06%) than the resistance at $0.430 (6.20%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Protagenic Therapeutics, Inc. Common Stock stock A Buy?

Protagenic Therapeutics, Inc. Common holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.233 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 17, 2026 - $0.405 ( 0%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk